FZD7 and hepatocellular carcinoma: Accordingly, Nambotin et al. demonstrated that pharmacological inhibition of FZD7 displayed anti-cancerous properties against HCC in vitro (on a panel of human HCC cell lines) and in vivo (on the SV40–TAg transgenic mouse model of HCC) [121].